Advancing Molecular Discovery in Biopharma

Compound screening is a fundamental step in drug discovery. Both high-throughput screening and virtual screening rely on rich compound resources as sources of potential leads. Virtual screening enables the rapid and efficient evaluation of vast numbers of compounds in a short time, and therefore requires extensive structural information to support the process. At the same time, the results of virtual screening must be validated through biological activity assays, making it ideal for compounds to be readily available for purchase, thereby accelerating the research workflow.
110K+
Bioactive Compounds
26M+
Novel & Diverse Drug-like Compounds
18W+
Natural compounds & derivatives
460K+
Fragment Compounds
AnyMol has an professional team engaged in high-throughput screening, virtual screening, activity studies, and animal experiments. We aim to break down barriers in drug discovery and development process and build a one-stop platform for drug screening, providing scientists worldwide with transparent access to research chemicals and product services, as well as reliable and professional preclinical drug development services.
discovery

「Featured」Product Lines

ADC- Products

Antibody–drug conjugates (ADCs)
Antibody–drug conjugates (ADCs) are composed of monoclonal antibodies targeting tumor-associated antigens, conjugated via linkers to varying numbers of small-molecule cytotoxic agents. They combine the high specificity of monoclonal antibody therapeutics with the potent antitumor activity of cytotoxic drugs within tumor tissues.

ADC Antibody

The conjugation between the antibody and the payload in ADCs is a key determinant of their safety and efficacy.

Antibody-Drug Conjugates (ADCs)

Antibody–drug conjugates (ADCs) are composed of monoclonal antibodies targeting tumor-associated antigens, conjugated via linkers to varying numbers of small-molecule cytotoxic agents. They combine the high specificity of monoclonal antibody therapeutics with the potent antitumor activity of cytotoxic drugs within tumor tissues.

ADC Cytotoxin

ADC cytotoxic agents (also known as payloads) are the primary source of cytotoxicity in ADCs. These cytotoxins are the most critical component of an ADC, as they determine its potency in killing cancer cells.

Drug-Linker Conjugates for ADC

The linker connects the antibody to the cytotoxic payload and is a critical component of antibody–drug conjugates (ADCs). It imparts the following properties to ADCs:
(1) High stability in circulation
(2) Targeted release of the payload in specific tissues.

ADC Linker

ADC linkers play a critical role in ADC design, as they connect the cytotoxic drug to the monoclonal antibody. There are two main types of linkers: non-cleavable and cleavable.

PROTAC-Linker Conjugates for PAC

Proteolysis-targeting chimera–antibody conjugates (PACs) combine the specificity of antibodies with the protein-degrading capability of proteolysis-targeting chimeras (PROTACs), enabling targeted degradation of disease-associated proteins.

AI+ Drug Discovery Platform

Computer Aided Drug Design

Computer-Aided Drug Design (CADD) is a method based on theoretical calculations of molecular structures. It uses computational modeling and simulations to predict interactions between drugs and biological targets, enabling the design and optimization of lead compounds.

Learn More  

Artificial Intelligence Drug Design

AnyMol leverages advanced CADD technologies—including molecular docking, molecular dynamics simulations, de novo drug design, similarity screening, and 3D-QSAR modeling—to rapidly and efficiently build diverse derivative compound libraries with novel structures, functional diversity, and strong relevance to drug discovery.

Learn More  

Activity Screening

Compound activity screening is a key step in modern drug discovery, aimed at identifying compounds with specific biological activities. It refers to the process of selecting highly active compounds against a particular target or phenotype from large compound collections using standardized experimental approaches. This process integrates multiple technologies into a comprehensive and systematic screening platform.

Learn More  

Start Your Order!

Search for your compound

Place your order online

Order processing & confirmation

Real-time order tracking

Fast & reliable delivery

Order Process
Order Process
Order Process

Leading Global Drug Discovery Platform-Compound Services

Customized Sample
Packaging

AnyMol has an experienced technical team and precise weighing instruments to accurately weigh the various packaged compounds you order and transfer them to standard reagent storage bottles for easier experimentation and storage management.

Active Test Solution
Configuration

Compound dissolution can be time-consuming and labor-intensive, especially when handling large libraries. AnyMol provides a dedicated platform for sample preparation, allowing rapid dissolution of large numbers of compounds to specified concentrations, delivering a cost-effective solution for sample processing.

Independent Quality
Control Service

AnyMol offers analytical services including HNMR, LC-MS, and HPLC. By combining multiple analytical techniques, robust quality control can be achieved. With years of experience in compound analysis, AnyMol’s specialists can efficiently verify structure and purity, and provide comprehensive analytical reports.

International Logistics
Customs Clearance

International shipping of chemicals is often complex and time-intensive, requiring professional handling. AnyMol has extensive experience in logistics and customs clearance, along with standardized operational workflows, ensuring a smooth and hassle-free ordering experience for customers.

TargetMol | Target Loading
Loading ~